Edward R. Conner
Senior VP & CMO, SANGAMO THERAPEUTICS, INC.
Companies
- Ardelyx (United States)Chief Medical Officer Oct 17, 2025 to now1
- Third Harmonic Bio, Inc.Chief Medical Officer Sep 14, 2022 to now2
- Enliven Therapeutics, Inc.Board member Apr 23, 2020 to Jun 3, 20223
- Audentes Therapeutics, Inc.SVP, Chief Medical Officer Jul 17, 2019 to Jan 15, 20204
- SANGAMO THERAPEUTICS, INCSenior VP & CMO Dec 2, 2016 to Jan 28, 20195
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ardelyx (United States) ARDX302,260 shares6$937.0K at $3.10Oct 17, 2025
- Third Harmonic Bio, Inc.0 shares7Nov 8, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 8, 2024Sold 2,117 shares at $15.00 of Third Harmonic Bio, Inc.7
- Nov 8, 2024Exercised options 2,117 shares at $4.20 of Third Harmonic Bio, Inc.7
- Oct 28, 2024Sold 2,673 shares at $15.00 of Third Harmonic Bio, Inc.8
- Oct 28, 2024Exercised options 2,673 shares at $4.20 of Third Harmonic Bio, Inc.8
- Sep 19, 2024Sold 4,790 shares at $15.00 of Third Harmonic Bio, Inc.9
- Sep 19, 2024Exercised options 4,790 shares at $4.20 of Third Harmonic Bio, Inc.9
- Dec 5, 2023Sold 4,790 shares at $10.03 of Third Harmonic Bio, Inc.10
- Dec 5, 2023Exercised options 4,790 shares at $4.20 of Third Harmonic Bio, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Oct 30, 2024
- 9SEC EDGARForm 4 filed Sep 20, 2024
- 10SEC EDGARForm 4 filed Dec 7, 2023